Literature DB >> 16401729

Subjective complaints precede Parkinson disease: the rotterdam study.

Lonneke M L de Lau1, Peter J Koudstaal, Albert Hofman, Monique M B Breteler.   

Abstract

BACKGROUND: Neuronal degeneration and dopamine loss in the preclinical phase of Parkinson disease may produce subtle complaints before clinically recognizable symptoms emerge.
OBJECTIVE: To examine whether subjective complaints of stiffness, slowness, tremors, or postural imbalance in persons without clinical signs of parkinsonism are related to an increased risk of future Parkinson disease.
DESIGN: Population-based cohort study. We recorded subjective complaints of stiffness, slowness of movement, tremors, falling, or a feeling of imbalance in a standardized interview of 6038 participants without dementia in whom no parkinsonian signs were found on physical examination at baseline, and we studied them prospectively for the occurrence of incident Parkinson disease.
SETTING: General population. PARTICIPANTS: A total of 6038 participants who were free of dementia and parkinsonian signs. MAIN OUTCOME MEASURES: Incident Parkinson disease. Participants were examined in person both at baseline (January 1990-June 1993) and at 2 follow-up visits (September 1993-December 1994 and April 1997-December 1999), and the cohort was continuously monitored through computerized linkage of the study database to general practitioners' medical records. We analyzed the data using Cox proportional hazards regression models.
RESULTS: Participants who reported stiffness, tremors, or imbalance at baseline had a significantly increased risk of developing Parkinson disease during follow-up (for stiffness, hazard ratio, 2.11; 95% confidence interval, 1.25-3.55; P = .005; for tremors, hazard ratio, 2.09; 95% confidence interval, 1.12-3.90; P = .002; and for imbalance, hazard ratio, 3.47; 95% confidence interval, 1.69-7.00; P = .001).
CONCLUSIONS: Subjective complaints of stiffness, tremors, and imbalance are associated with an increased risk of future Parkinson disease and may reflect early effects of dopamine shortage, even when standard neurological testing cannot yet demonstrate any motor symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16401729     DOI: 10.1001/archneur.63.3.noc50312

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Low muscle strength in late adolescence and Parkinson disease later in life.

Authors:  Helena Gustafsson; Jan Aasly; Stefan Stråhle; Anna Nordström; Peter Nordström
Journal:  Neurology       Date:  2015-04-03       Impact factor: 9.910

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

Review 3.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Relation of risk factors and putative premotor markers for Parkinson's disease.

Authors:  I Liepelt-Scarfone; S Behnke; J Godau; K J Schweitzer; B Wolf; A Gaenslen; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

5.  Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects.

Authors:  Nicolaas I Bohnen; Martijn L T M Muller; Hiroto Kuwabara; Rakié Cham; Gregory M Constantine; Stephanie A Studenski
Journal:  J Rehabil Res Dev       Date:  2009

6.  Risk factors and prodromal markers and the development of Parkinson's disease.

Authors:  Stefanie Lerche; Klaus Seppi; Stefanie Behnke; Inga Liepelt-Scarfone; Jana Godau; Philipp Mahlknecht; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Werner Poewe; Daniela Berg
Journal:  J Neurol       Date:  2013-11-05       Impact factor: 4.849

7.  Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson's disease.

Authors:  Uwe Walter; Sabine Kleinschmidt; Florian Rimmele; Christian Wunderlich; Irene Gemende; Reiner Benecke; Knut Busse
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

8.  The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease.

Authors:  Alexandra Gaenslen; Irene Swid; Inga Liepelt-Scarfone; Jana Godau; Daniela Berg
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

9.  Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.

Authors:  Michelle Beavan; Alisdair McNeill; Christos Proukakis; Derralynn A Hughes; Atul Mehta; Anthony H V Schapira
Journal:  JAMA Neurol       Date:  2015-02       Impact factor: 18.302

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.